(Q40751811)

23 September 2017

Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

23 September 2017

0 references

1 reference

16

1 reference

23 September 2017

Roberto Pastor-Barriuso

7

object named as

Roberto Pastor-Barriuso

0 references

Mariana Lazo

6

object named as

Mariana Lazo

1 reference

23 September 2017

15

Eliseo Guallar

1 reference

23 September 2017

Yoosoo Chang

1

1 reference

23 September 2017

Hyun-Suk Jung

2

1 reference

23 September 2017

Juhee Cho

3

1 reference

23 September 2017

Yiyi Zhang

4

1 reference

23 September 2017

Kyung Eun Yun

5

1 reference

23 September 2017

Roberto Pastor-Barriuso

7

1 reference

23 September 2017

Jiin Ahn

8

1 reference

23 September 2017

Chan-Won Kim

9

1 reference

23 September 2017

Sanjay Rampal

10

1 reference

23 September 2017

Miguel Cainzos-Achirica

11

1 reference

23 September 2017

Di Zhao

12

1 reference

23 September 2017

Eun Cheol Chung

13

1 reference

23 September 2017

Hocheol Shin

14

1 reference

23 September 2017

language of work or name

English

0 references

publication date

17 May 2016

1 reference

The American Journal of Gastroenterology

23 September 2017

1 reference

23 September 2017

111

1 reference

23 September 2017

8

1 reference

23 September 2017

1133-1140

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2016.178

23 September 2017

0 references

cites work

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Nonalcoholic fatty liver disease and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Obesity-associated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Characterizing the profile of obese patients who are metabolically healthy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Need for a paradigm shift in adult overweight and obesity management - an EASO position statement on a pressing public health, clinical and scientific challenge in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Is it finally time to dispel the concept of metabolically-healthy obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Are metabolically normal but obese individuals at lower risk for all-cause mortality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Metabolically-healthy obesity and coronary artery calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Age at menarche and non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Gender and racial differences in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Defining nonalcoholic fatty liver disease: implications for epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

The number of years lived with obesity and the risk of all-cause and cause-specific mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

The duration of obesity and the risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.178

Prevalence of and risk factors for hepatic steatosis in Northern Italy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27185080

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27185080

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The endocrine function of adipose tissue: an update

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27185080

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/AJG.2016.178

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference